Alpha-1-Antitrypsin Deficiency

Pavel Strnad is an Associate Professor and Senior Physician at the University Hospital Aachen, Aachen, Germany. He currently leads a European initiative for the study of AATD-associated liver disease. Mark L. Brantly is a Professor of Medicine and Chief of Molecular Genetics and Microbiology in the Division of Pulmonary, Critical Care and Sleep Medicine at the University of Florida College of Medicine in Gainesville (FL, USA), where his is also the Alpha-1 Foundation Research Professor. Robert Bals is the Director of the Saarland University's (Saarbrücken, Germany) Department of Pulmonology, where he focuses on teaching, research and patient care. Robert Bals established and manages the German AAT Registry.

Patient view; Serpinopathies; Genetics and epidemiology; Laboratory diagnosis; Mechanisms of lung disease; Clinical approach to diagnosis and assessment; Treatment of lung disease; Mechanisms of liver disease; Clinical approach to paediatric liver disease; Clinical approach to liver disease in adults; Rare manifestations; Genetic counselling; Registries: roles, objectives and registry data study outcomes; Future directions: diagnostic approaches and therapy with AAT